In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014–2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment

In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014–2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment

ABSTRACT: Objectives: To evaluate the susceptibility of globally pneumonia-causing meropenem-resistant (MEM-R) Acinetobacter baumannii isolates against important antibiotics and estimate appropriate dosages of indicated antibiotics. Methods: We extracted the 2014–2021 Antimicrobial Testing of Leade...

Full description

Bibliographic Details
Main Authors: Shun-Chung Hsueh, Yu-Tsung Huang, Wen-Chien Ko, I-Min Liu, Po-Chuen Hsieh, Shio-Shin Jean
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Susceptibility breakpoint
Meropenem-resistant
Acinetobacter baumannii
Colistin
Minocycline
Tigecycline
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716524000249

Internet

http://www.sciencedirect.com/science/article/pii/S2213716524000249

Similar Items